Cash Flow PharmaCyte Biotech, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Apr'25
Apr'24
Apr'23
Apr'22
Apr'21
Apr'20
No of Months
12
12
12
12
12
12
Profit Before Tax
30.00
0.00
-4.00
-4.00
-3.00
-3.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
0.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-2.00
-2.00
-3.00
-4.00
-3.00
-2.00
Cash Flow from Investing Activities
-7.00
-5.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
-25.00
-10.00
-13.00
87.00
4.00
2.00
Net Cash Inflow / Outflow
-35.00
-17.00
-17.00
83.00
1.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PharmaCyte Biotech, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
30.65605
-7.00264700000194
37.00
537.78%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.356333
0.100123000000028
1.00
1254.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-2.978296
-2.66945600000074
0.00
-11.57%
Cash Flow from Investing Activities
-7
-27.0463410000075
20.00
74.12%
Cash Flow from Financing Activities
-25.029151
29.006249000008
-54.00
-186.29%
Net Cash Inflow / Outflow
-35.007805
-0.68288700000019
-35.00
-5026.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.000358
0.0266610000000074
0.00
-101.34%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Apr'25
YoY Growth in year ended Apr 2025 is -38.43% vs 43.29% in Apr 2024
Apr'25
Apr'24
Change(%)
Cash Flow from Operating Activities
-2.98
-2.15
-38.43%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
